BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21997545)

  • 1. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
    Pence BC; Belasco EJ; Lyford CP
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.
    Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S
    Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
    DuPont AW; Arguedas MR; Wilcox CM
    Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
    Hur C; Simon LS; Gazelle GS
    Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Benamouzig R
    Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk analyses for screening sigmoidoscopy based on a colorectal cancer (CRC) population.
    Mulder SA; Ouwendijk RJ; Giard RW; Van Leerdam ME; Kuipers EJ
    Scand J Gastroenterol; 2009; 44(2):205-10. PubMed ID: 18836946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.